Intervention design for artificial intelligence-enabled macular service implementation: a primary qualitative study

Henry David Jeffry Hogg1,2,3, Katie Brittain4, James Talks5

  • 1Research, Development and Innovation, University Hospitals Birmingham NHS Foundation Trust, Level 2 ITM, Queen Elizabeth HospitalMindelsohn Way, Birmingham, B15 2GW, UK. J.Hogg.1@bham.ac.uk.

PubMed
Summary

Artificial intelligence (AI) can optimize neovascular age-related macular degeneration (nAMD) treatment scheduling. This study guides early adopters on implementing AI to improve macular services and patient outcomes.

Related Concept Videos